Andrew Strong, a partner at the law firm Pillsbury Winthrop Shaw Pittman, has extensive experience in managing significant matters on behalf of the firm’s clients including handling corporate and securities, private and public financing, legislative, judicial, regulatory and administrative matters.
Andrew represents public- and private-sector clients in the emerging technology, life sciences, energy, and real estate industries; public and private academic institutions; and governmental bodies on a variety of diverse matters. His experience in the board room for private and public companies to his experience in a court room or before a legislative or administrative body has helped hone his skills in representing small to large clients. Andrew previously served as the General Counsel and Compliance Officer for the Texas A&M University System where he was responsible for, among other things, crisis management and internal investigations for the System’s 11 public universities, seven state agencies and health science center. He was the President and CEO of a startup biotech company (Kalon Biotherapeutics) which he successfully grew and sold to Fujifilm and Mitsubishi. Andrew now serves on the boards of two publicly traded companies.
Ted Koutouzis is a venture capitalist and medicine man. He is an analyst at Magnetar Capital, and the Managing Director at Reimagined Ventures. Koutouzis graduated from Florida State University with a BS in Nutrition/Exercise Science and an MD from the University of Miami School of Medicine. He received his graduate degree in Emergency medicine from Northwestern University. Koutouzis practices emergency medicine at Northwestern Memorial Hospital. In addition, Koutouzis has worked at Magnetar Capital since 2006. For the first ten years he focused on risk arbitrage investments at the equity desk and later moved on to the fixed income team where he was responsible for the underwriting process for structured finance solutions across the life sciences. He is the Managing Director at Reimagined Ventures where he co-manages all healthcare investments. He also sits on the board at Neural Analytics, a company that received a ten million dollar investment from Reimagined Ventures.